From Fortune 500 to Startup: PharmExec Features PABC, a former CEO of Novartis and a PABC Member Company's CEO »click here» 

Local Reach, Global Impact
215-589-6300

Companies Engaged in Hepatitis B Vaccine & Therapeutics R&D

You can track the stock prices of publicly traded companies engaged in hepatitis B vaccine and therapeutics research and development with our new and unique "stock ticker." Please note that all prices shown may be delayed up to half an hour.

 

HBRI - Hepatitis B Research Index   $574.00   -0.328% 
ALT - Altimmune, Inc.   $23.92   5.930% 
ARWR - Arrowhead Pharmaceuticals, Inc.   $42.17   -1.490% 
ABUS - Arbutus Biopharma Corporation   $3.36   -5.580% 
ASMB - Assembly Biosciences, Inc.   $20.57   -1.110% 
DRNA - Dicerna Pharmaceuticals, Inc.   $19.44   -1.270% 
DVAX - Dynavax Technologies Corporation   $6.82   -0.940% 
ENTA - Enanta Pharmaceuticals, Inc.   $49.11   2.040% 
HEPA - Hepion Pharmaceuticals, Inc.   $3.79   -5.850% 
NTLA - Intellia Therapeutics, Inc.   $20.63   1.030% 
SBPH - Spring Bank Pharmaceuticals, Inc.   $1.47   0.680% 
VIR - Vir Biotechnology, Inc.   $52.71   -0.300% 
BBI - Brickell Biotech Inc.   $0.82   -7.740% 

Publicly Traded Companies

Listed below are the publicly traded companies we are tracking. If you have one to suggest, please email edward.tate@bblumberg.org.

ABUS - Arbutus Biopharma Corporation

ALT - Altimmune Inc.

ARWR - Arrowhead Pharmaceuticals Inc.

ASMB - Assembly Biosciences Inc.

BBI - Brickell Biotech Inc.

DRNA - Dicerna Pharmaceuticals Inc.

DVAX - Dynavax Technologies Corp.

ENTA - Enata Pharmaceuticals Inc.

HBRI - Hepatitis B Research Index
(market value-weighted representation of public companies listed)

HEPA - Hepion Pharmaceuticals Inc.

NTLA - Intellia Therapeutics Inc.

SBPH - Spring Bank Pharmaceuticals Inc.

VICLBrickell Biotechnologies

VIRB - Vir Biotechnology Inc.